Skip to main content
logo
Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0278
-0.0022 (-7.33%)
At close: Jun 4, 2026

Adaptimmune Therapeutics Revenue

In the year 2025, Adaptimmune Therapeutics had annual revenue of $5.92M, down -96.67%.

Revenue
5.92M
Revenue Growth
-96.62%
P/S Ratio
1.24
Revenue / Employee
11.71K
Employees
506
Market Cap
7.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.92M-172.11M-96.67%
Dec 31, 2024178.03M117.75M195.34%
Dec 31, 202360.28M33.13M122.05%
Dec 31, 202227.15M21.00M341.50%
Dec 31, 20216.15M2.19M55.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Adaptimmune Therapeutics News

More News